CRNX | Crinetics PharmaceuticalsNASDAQCommon stock golden cross and death cross projections, cross tests and history

$84.95
+$0.11 (+0.13%)

Crinetics Pharmaceuticals (CRNX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

CRNX stopped trading under this ticker on 31 Aug 2026.

Timeframe summary

Daily as of 31 Aug 16:00 ET

Price
above both $84.95 vs 50 $74.83 / 200 $50.44
Projection
No cross projected
Test
No active test
Last cross
Golden cross 16 Jul 2026 ยท projected 7 bars out

Weekly as of 4 Sep 16:00 ET

Price
above both $84.95 vs 50 $49.61 / 200 $37.82
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 18 Sep 2023 ยท projected 1 bar out

4-hour as of 31 Aug 16:00 ET

Price
above both $84.95 vs 50 $84.39 / 200 $56.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross 8 Jul 2026 ยท projected 21 bars out

Cross history

25
crosses on record since 2020
13 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
16 Jul 2026Golden steepdaily7 bars outNot tested
8 Jul 2026Golden4-hour21 bars outNot tested
15 Apr 2026Death steepdaily30 bars out7 bar cross test
2 Mar 2026Death4-hour27 bars outNot tested
10 Oct 2025Golden steepdaily24 bars outNot tested

About CRNX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$207M
4-hour coverageYes, since Oct 2025
History on recordSince 2020

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.